Many studies have considered the association between Medicare spending and health outcomes at a point in time; few have considered the association between the long-term growth in spending and outcomes.
W ith potential cuts in federal support for health insurance, the question of how these spending reductions might adversely affect population health is of particular importance. There is little agreement regarding the association between health care expenditures and outcomes, with estimates ranging from large and positive to 0 or negative. [1] [2] [3] [4] [5] [6] [7] Although it is well understood that not all spending is cost-effective, nearly all studies have summarized the multidimensional components of patient care by a single dollar measure-total expenditures-rather than considering how the money is spent (ie, for cost-effective or ineffective services).
To address these knowledge gaps, we use a large longitudinal patient-level database from the Medicare fee-for-service population of elderly patients admitted to the hospital for acute myocardial infarction (AMI) between January 1, 1999, and June 30, 2014. Based on previous evidence documenting differential rates of spending growth across the United States, 8, 9 we hypothesized that hospitals have experienced different patterns of growth (or even decline) in treatment intensity for patients with AMI, with some hospitals investing most heavily in postacute care and others focusing on increasing the use of early percutaneous coronary interventions (PCIs), other cardiac procedures, imaging, or physician services. We further hypothesized that risk-and inflation-adjusted growth in total Medicare spending is not the most important determinant of overall health outcomes, but that the components of spending growth, whether on cost-effective or cost-ineffective services, should have a greater impact on health outcomes. We therefore consider, separately, the association between the change in health outcomes from 1999 through 2014 and the diffusion of several treatment modalities during the same period, including those previously found to be cost-effective (ie, early PCI 10, 11 ) and those less supported by evidence, 12 ,13 such as testing and imaging, physician visits, cardiac and noncardiac procedures, outpatient care, and postacute care (including skilled nursing facilities, home health agencies, hospice, and durable medical equipment).
Methods
This study was approved by the Dartmouth institutional review board. Given the retrospective nature of this study, participant informed consent was not required.
Data
We The sample included those (1) enrolled in Medicare (Part A and Part B, as identified through the Medicare denominator file) for the entire year beyond their index admission (or until the month of their death), (2) aged at least 65 years at the time of their index admission, and (3) enrolled in a non-health maintenance organization plan for at least 1 month during each of the 12-month periods. Data from the Medicare provider analysis and review files were linked to other files (carrier file, home health agency, durable medical equipment, outpatient, and hospice) containing claims that represented services associated with the patient's index admission and subsequent services (and expenditures) for a 180-day period following admission. Outpatient claims include bills from rehabilitation facilities, hospital outpatient departments, and other institutional outpatient health care providers.
We excluded patients admitted to a non-acute care hospital with a primary diagnosis of AMI, those transferred to an acute care hospital with a primary diagnosis other than AMI, and those discharged alive and not transferred with a total length of stay of 1 day or less. We defined a transfer as occurring if the date of discharge was the same as the date of admission between 2 mutually exclusive hospitals. The total length of stay for the index admission was defined from the date of admission to discharge, including any transfers.
Primary Outcome
The primary outcome measure is the risk-adjusted 180-day case fatality (or mortality) rate. In the sensitivity analysis, we also considered the risk-adjusted 30-day and 31-to 180-day (conditional on surviving 30 days) case fatality rates.
Hospital Payments
Hospital payments included those associated with the acute index hospitalization (diagnosis related group payment plus outlier payments when present) and other hospitalizations occurring within 180 days of the initial admission date. Expenditures included actual payments to health care professionals, absent amounts billed to patients or their supplemental insurance policies.
Physician Payments and Utilization
We provide utilization and payments for physician services based on Current Procedural Terminology and BerensonEggers Type of Service (BETOS) codes.
15 Through these codes, we identified utilization of PCI and coronary artery bypass grafting (CABG) surgery. The BETOS codes create clinically relevant service categories for analyzing payments (eg, testing and imaging, physician visits, and cardiac and noncardiac procedures).
Other Expenditures After the Index Hospitalization
We included expenditures for skilled nursing facilities, outpatient services, home health agencies, hospice, and durable medical equipment.
Statistical Analysis
The analysis was performed at the individual patient level for 1999, 2000, 2004, 2008, 2013, and 2014 . Logistic regressions, restricted to hospitals appearing in all years and treating at least 10 patients hospitalized with AMI per year, were used to estimate the models, with marginal probability estimates (using the "margin dydx(), atmeans" command in Stata version 14.0 Statistical Software [StataCorp LP]) reported in the tables and with standard errors clustered at the hospital referral region level appearing in parentheses (using the "cluster (hrr)" command in Stata version 14.0). We used 2 types of exposure measures, calculated at the hospital level. Our first exposure was based on overall 180-day price-and inflation-adjusted expenditures dollar levels. 7, 16 Given that marginal health benefits may vary according to how money is spent, we further stratified spending into 6 categories: (1) testing and imaging, (2) physician visits, (3) cardiac procedures, (4) other procedures, (5) hospital care based on Medicare Part A spending, and (6) postacute care (with further breakdown into skilled nursing facility, home health, hospice, and durable medical equipment). Components of physician spending were categorized using BETOS codes. The second exposure focused on utilization for a highly effective AMI treatment [17] [18] [19] : the share of patients receiving PCI on the first day of the index hospitalizations for AMI (early PCI). To understand whether PCI substituted for other types of services, we also assessed whether changes in early PCI rates were associated with changes in 180-day spending and 180-day CABG surgery.
To account for differences across patients (and over time) in underlying health status, we adjusted for the beneficiary's age, sex, race/ethnicity, and Charlson comorbidity index 20 (presence of vascular disease, pulmonary disease, asthma, dementia, diabetes mellitus, liver and renal disorders, and cancer). To adjust further for potential confounding, we measured hospital-level exposure rates for those surviving the entire 180 days after index hospitalization. We included hospital-level categorical variables to adjust for unmeasured differences in health status across hospitals that may otherwise bias our results. 21, 22 We included categorical variables for the admission year, to adjust for general trends and other unobservable confounding factors that evolve over time. Statistical analyses were performed using Stata version 14 and SAS version 9.4 (SAS Institute Inc) statistical software. We additionally tested interaction terms for quartiles of AMI volume and early PCI utilization rates, and additionally by STelevation myocardial infarction (STEMI) vs non-ST-elevation myocardial infarction (NSTEMI) (eTable 1 in the Supplement). We also conducted sensitivity analyses (eAppendix in the Supplement).
Results
We identified 479 893 Medicare beneficiaries who were hos- As shown in Table 1 
Growth in Total 180-Day Medicare Expenditures
Overall inflation-and risk-adjusted 180-day mean expenditures per patient increased by 13.9% ($4486) between 1999-2000 and 2013-2014 ( Table 2 ). All of the increase occurred by 2008, 14.5% ($4654), with a 0.5% decline in risk-and inflationadjusted spending between 2008 and 2013-2014. Total spending grew 6.1% up to 30 days beyond the index admission, and 31.0% from 31 to 365 days beyond the index admission. There was considerable heterogeneity in 180-day growth rates across hospitals. Spending in the 61 hospitals (or 5% of all hospitals) with the slowest expenditure growth decreased 18.7% (−$7384; 95% CI, −$8177 to −$6496), while spending in the 61 hospitals with fastest expenditure growth grew increased 44.1% ($12 828; 95% CI, $12 084 to $13 890). Spending on inpatient services per beneficiary grew by just $417 (1.8%) between 1999-2000 and 2013-2014, and median length of stay decreased by 2 days during the same period (P < .001). During this same period, physician and outpatient spending increased by $1582 (outpatient spending increased by $1818 per beneficiary); 44% of the change in physician and outpatient spending was associated with cardiac procedures (change in spending for cardiac procedures/change in physician and outpatient spending, $684), while hospital visits accounted for an additional 22% of spending (change in mean spending for hospital visits/change in physician and outpatient spending, $347).
Growth in PCI Rates and Decline in CABG Rates
Utilization of PCI through 180 days increased by 48.9% between 1999-2000 and 2013-2014 (mean, 0.309 vs 0.460, respectively), while early (same day as admission) PCI utilization increased by 102.9% (mean, 0.173 vs 0.351, respectively). Only 1.7% of patients with AMI were treated in hospital-years in which no other patient at the hospital received early PCI. Between 1999-2000 and 2013-201414, 180-day CABG rates decreased by 35.3% (mean, 0.167 vs 0.108, respectively). This latter finding may be explained by the fact that we restricted to hospitals with at least 11 patients with AMI every year.
We investigated whether hospitals that increased their early PCI use simultaneously decreased their use of other services. Changes in 180-day CABG rates were only weakly correlated with changes in early (r = −0.099) or 180-day (r = −0.164) PCI rates. We further decomposed the type of postacute care spending associated with growth in early PCI. We found that hospitals that increased their use of early PCI the most (ie, fourth quartile), relative to the lowest growth quartile, had lower 180-day per-beneficiary mean spending for skilled nursing facilities (−$700) as well as home health agency, hospice, and durable medical equipment (−$298)( eTable 2 in the Supplement).
Association Between Health Care Spending and Case Fatality Rates
Changes in 180-day spending were weakly associated with riskadjusted case fatality, using either bivariate correlations at the hospital level (Figure 1 ) or multivariate regression analysis at the patient level (Table 3) . However, changes in early PCI were strongly and inversely associated with 180-day case fatality (Figure 2) . In multivariable analysis controlling for other measures of 180-day spending, early PCI rates were inversely associated with 180-day mortality (β = −0.079, P < .001) ( Table 3) . This finding was stronger among patients with STEMI (β = −0.172, P < .001) relative to those with NSTEMI (β = −0.0912, P < .001), and persisted even after controlling for CABG utilization (β = −0.078, P < .001) and other spending components (β = −0.078, P < .001) (eTable 3 in the Supplement). We found a significant interaction between quartiles of AMI volume and early PCI rates on 180-day mortality, whereby the greatest reductions in mortality attributed to early PCI were among those hospitals with the highest average AMI volume. This volume effect occurred solely among patients with NSTEMI (P = .008) (eTable 4 in the Supplement).
Increases in 180-day case fatality rate were associated positively with cardiac procedure spending (β = 0.004, P = .007), and negatively with postacute care (β = −0.002, P < .001), the latter of which translates to a costeffectiveness ratio of $455 000 per life saved (95% CI, $323 000-$833 000) ( Table 3) . In a sensitivity analysis that examined the composition of postacute care spending (eTable 3 in the Supplement), only spending on skilled nursing facilities and early PCI rates exhibited significant negative associations with case fatality rates (P < .001). After holding early PCI rates constant, no other component of spending had a statistically significant association with 180-day fatality, including spending on physician visits. Changes in hospital rates of early percutaneous coronary interventions, performed within a day of admission. Solid line represents fitted values. which may be explained if diffusion of early PCI was also associated with other improvements (eg, quicker door-toballoon time). We found no evidence that hospitals scaling back on CABG surgery increased early PCI use. We previously argued that when different components of health care spending exhibit higher or lower costeffectiveness, total expenditures and growth are poor predictors of overall health benefits. 27 Our results are consistent with this hypothesis. Factors leading to improved outcomes have little impact on spending, while the factors leading to the highest impact on spending have a modest impact on health outcomes. 28 Postacute care, specifically, nursing home care, which grew rapidly, offered a cost-effectiveness of $455 000 per additional life saved at 180 days. Unlike previous studies that did not find reduced case fatality attributed to postacute care, 12,13 we consider only patients with AMI, and for these patients cardiac rehabilitation has previously been associated with a 20% reduction in all-cause mortality and a costeffectiveness of $8691 (in 2014 dollars) per year of life saved. 34 Third, we did not have a full accounting of all spending components (eg, pharmaceutical, supplemental insurance bills). Fourth, some potentially important components of spending were not accounted for in the present analysis (eg, pharmaceuticals). Fifth, while postacute care spending beyond 30 days may not be directly managed by the index hospital, there is increased awareness and management of postacute care by health systems attributed in part to further dissemination of Accountable Care Organizations and bundled payment programs. Sixth, we cannot rule out temporal differences in NSTEMI diagnosis attributed to the rapid diffusion of cardiac biomarkers during this period. Another limitation is a focus on mortality only rather than quality of life, a measure that is unfortunately beyond the scope of our nationally representative Medicare claims data.
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Conclusions
While minimal hospital variation existed in spending within the traditional 30-day episode-based reimbursement window, large variation in growth rates and treatment diffusion existed between 31 and 180 days beyond the index admission. Hospitals that increased early PCI use experienced improvements in health outcomes but did not experience large Changes in 180-day risk-adjusted case fatality by hospital rates of early percutaneous coronary interventions performed within a day of admission. Solid line represents fitted values; PCI, percutaneous coronary intervention.
overall cost increases. Policies encouraging hospitals to adopt early PCI, while supporting hospital-based and non-hospitalbased reductions in spending on less cost-effective services (perhaps through newly designed bundled payment programs), may help improve patient outcomes without increasing costs. 
